Hydroxyzine Pamoate Powder
NDC Package 66022-0122-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Hydroxyzine Pamoate powders is hydroxyzine is used to treat itching caused by allergies. This formulation utilizes a powder delivery system. Marketed by Symed Labs Limited, this product is identified by NDC 66022-0122.

Identification & Billing

NDC Package Code
66022-0122-1
Package Description
25 kg in 1 CONTAINER
Product Code
66022-0122
11-Digit Billing Format
66022012201

Clinical Specifications

Proprietary Name
Hydroxyzine Pamoate
Non-Proprietary Name
Hydroxyzine Pamoate
Substance Name
Hydroxyzine Pamoate
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
HYDROXYZINE PAMOATE 1 kg/kg
Usage Information
Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

Regulatory & Marketing

Labeler Name
Symed Labs Limited
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
06-23-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66022-0122-1 identifies a specific commercial package of 25 kg in 1 container of Hydroxyzine Pamoate (UNFINISHED drug), a bulk ingredient labeled by Symed Labs Limited. This powder is formulated for use and contains hydroxyzine pamoate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Symed Labs Limited on June 23, 2023. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Hydroxyzine is used to treat itching caused by allergies. It is an antihistamine and works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Hydroxyzine may also be used short-term to treat anxiety or to help you feel sleepy/relaxed before and after surgery.

How is this Symed Labs Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66022012201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
66022-0122-1
11-Digit CMS (5-4-2)
66022-0122-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.